Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in ...

Lewy body dementia – a broad term which includes ‘dementia with Lewy bodies’ and Parkinson’s dementia – can cause delusional ...

A trial to identify fast and accurate blood tests that can diagnose dementia comes at an "exciting" time in the treatment of ...

Researchers have unveiled a critical mechanism that links cellular stress in the brain to the progression of Alzheimer's disease (AD). The study highlights microglia, the brain's primary immune cells, ...

The figure is expected to climb to more than half a million diagnoses by the end of 2024. The NHS is urging individuals to ...

According to latest figures, a record number of people have received a dementia diagnosis in England - here are the signs to ...

David Gergen was recently diagnosed with Lewy body dementia. His daughter, Katherine Gergen Barnett, reveals the wisdom she ...

Researchers have combined two sequencing technologies in single cells to find new differences in mRNAs resulting from Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease.

B. Riley analyst Mayank Mamtani upgraded Cognition Therapeutics (CGTX) to Buy from Neutral with a price target of $1.50, up ...

H.C. Wainwright raised the firm’s price target on Cognition Therapeutics (CGTX) to $6 from $5 and keeps a Buy rating on the shares. The company ...

THURSDAY, Dec. 19, 2024 (HealthDay News) -- Parkinson's is a relentless disease for which few treatments, and no real cure, ...

Lewy body dementia (LBD) is a progressive brain disorder that affects thinking, movement, and behavior. It is the second most ...